PP-001

· Panoptes Pharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PP-001, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis [Phase 1, Phase 2]